NASDAQ Equity Snapshot
HURA Weekly Equity Report
TuHURA Biosciences Inc
What the company does
TuHURA Biosciences Inc is an innovative biotechnology company at the forefront of developing cutting-edge immunotherapy solutions designed to transform the treatment landscape for cancer and autoimmune diseases. Leveraging a strong research pipeline, the company is focused on harnessing the full capabilities of the human immune system to improve patient outcomes and address unmet medical needs. With strategic partnerships and a commitment to pioneering technologies, TuHURA is well-positioned for long-term growth and value creation in the dynamic biopharmaceutical industry, aiming to become a key influencer in the future of healthcare.
What the weekly tape is saying
HURA closed the latest completed week at 2.32 USD. The 4-week return is 0.4% and the 12-week return is 19.6%. Trend Signal is active, Market Dynamics is 0.42. Setup signature: Risk-first tape with a 36/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.62 USD
- Vs Trend Line
- 42.8%
- Fair Value
- 21.09 USD
- Vs Fair Value
- -89.0%
- 52W High
- 3.90 USD
- 52W Low
- 0.41 USD
- Drawdown
- -40.5%
- Range Position
- 54.7%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 6 weeks
- 52W Active Weeks
- 6
- 52W Active Breadth
- 11.5%
- Sector Scope
- US Healthcare
- Sector Rank
- 35 of 1038
- Sector Percentile
- 96.7%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.42
- 4W MD Change
- -54.7%
- Relative Strength
- -3.02
- 4W RS Change
- 54.3%
- Expectation
- Negative
- Probability
- 39.37%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.9M
- 13W Average
- 4.1M
- 52W Average
- 3.9M
- Vs 13W
- 0.5x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 21.4%
- 52W Volatility
- 23.4%
- Upside Weeks
- 23
- Downside Weeks
- 29
- Downside Breadth
- 55.8%
- Avg Gain / Loss
- 19.0% / -11.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 143.9M
Opportunity signals
- Trend Signal is active with a 6-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Market Dynamics is positive on the latest completed week.
Risk signals
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.32 USD | 18.1% | 1.62 USD | 21.09 USD | 0.42 | -3.02 | 1.9M | On |
| 5 Jun 2026 | 1.97 USD | -13.1% | 1.62 USD | 21.88 USD | 0.59 | -16.67 | 2.5M | On |
| 29 May 2026 | 2.26 USD | -9.6% | 1.63 USD | 22.62 USD | 0.81 | -9.80 | 1.9M | On |
| 22 May 2026 | 2.50 USD | 8.2% | 1.64 USD | 23.38 USD | 0.89 | 1.03 | 3.3M | On |
| 15 May 2026 | 2.31 USD | -2.9% | 1.64 USD | 24.04 USD | 0.92 | -6.61 | 2.3M | On |
| 8 May 2026 | 2.38 USD | 2.1% | 1.64 USD | 24.68 USD | 1.00 | -6.31 | 3.7M | On |
| 1 May 2026 | 2.33 USD | -0.9% | 1.64 USD | 25.35 USD | 1.02 | -5.70 | 3.6M | Off |
| 24 Apr 2026 | 2.35 USD | -19.5% | 1.65 USD | 26.09 USD | 0.95 | -5.70 | 5.9M | Off |
| 17 Apr 2026 | 2.92 USD | 28.6% | 1.65 USD | 26.70 USD | 0.94 | 16.79 | 11.6M | Off |
| 10 Apr 2026 | 2.27 USD | 61.0% | 1.64 USD | 27.41 USD | 0.89 | -5.89 | 7.4M | Off |
| 2 Apr 2026 | 1.41 USD | -22.1% | 1.65 USD | 28.03 USD | 0.88 | -40.56 | 2.4M | Off |
| 27 Mar 2026 | 1.81 USD | -6.7% | 1.69 USD | 28.74 USD | 0.91 | -22.73 | 2.7M | Off |
| 20 Mar 2026 | 1.94 USD | 2.1% | 1.72 USD | 29.52 USD | 0.91 | -21.42 | 4.8M | Off |
| 13 Mar 2026 | 1.90 USD | 26.7% | 1.76 USD | 30.34 USD | 0.74 | -25.78 | 6.0M | Off |